HealthEconomy
China's Innovative Drug Industry at a Tipping Point: Xinhua
Xinhua calls for accelerated China innovative drug development as record BD deals top $100B and AI transforms R&D, but warns of weak basic research.
—6 min read
Tag
#Innovative Drugs
2 articles
HealthcarePolicy
China Launches 2026 Dual Drug Catalog for Innovation Access
China's NHSA launches 2026 dual catalog adjustment for medical and commercial insurance, introducing pre-application mechanisms and expanded eligibility.
—4 min read